Exclusive: Sofina To Lead PlatinumRx’s $32 Mn Funding At $200 Mn Valuation
In brief
Online pharmacy startup PlatinumRx, based in Bengaluru, is reportedly in talks to raise about $32 Mn in a round led by Belgium-based Sofina Ventures, according to sources. The deal could value the company between $150 Mn and $200 Mn. This comes about a year after its $6 Mn Series A. PlatinumRx was founded in 2023 and sells substitute medicines with the same composition as branded ones, aiming to cut costs for chronic and recurring prescriptions. It says it has served over 10 Lakh customers. Terms could still change, and the companies had not responded to questions when the story was published.
From the publisher
Online pharmacy startup PlatinumRx is in talks to raise around $32 Mn (over ₹300 Cr) in a funding round led…Excerpt from Inc42
Why it matters for student founders
Investors are still backing online pharmacy models built around affordability and access. For a student founder, a clear customer need, such as lower-cost medicines for long-term patients, can attract serious funding. Talks reported by sources can also shift, so treat any deal as unconfirmed until announced.
The headline and excerpt belong to Inc42. "In brief" and "Why it matters" are written by STARTIONS from the published story.
